Clioquinol and pyrrolidine dithiocarbamate complex with copper to form proteasome inhibitors and apoptosis inducers in human breast cancer cells
2005

Clioquinol and Pyrrolidine Dithiocarbamate as Cancer Treatments

publication Evidence: moderate

Author Information

Author(s): Daniel Kenyon G, Chen Di, Orlu Shirley, Cui Qiuzhi Cindy, Miller Fred R, Dou Q Ping

Primary Institution: Barbara Ann Karmanos Cancer Institute, Wayne State University

Hypothesis

Can clioquinol and pyrrolidine dithiocarbamate interact with copper to form proteasome inhibitors and induce apoptosis in human breast cancer cells?

Conclusion

Clioquinol and pyrrolidine dithiocarbamate can target copper in breast cancer cells to induce apoptosis without harming normal cells.

Supporting Evidence

  • Clioquinol and pyrrolidine dithiocarbamate can inhibit proteasome activity in breast cancer cells.
  • These compounds induce apoptosis in malignant breast cancer cells but not in normal cells.
  • Copper is required for the effectiveness of these compounds in inducing apoptosis.

Takeaway

Some medicines can work better on cancer cells because they can grab onto copper that cancer cells have a lot of, making them die while leaving normal cells safe.

Methodology

Breast cancer cell lines were treated with clioquinol or pyrrolidine dithiocarbamate with or without copper, followed by measurement of proteasome inhibition and cell death.

Limitations

The study primarily used immortalized breast cancer cell lines rather than true normal primary cell lines.

Digital Object Identifier (DOI)

10.1186/bcr1322

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication